The Rheumatoid Arthritis Diagnostic Tests Market Size is valued at USD 2.03 billion in 2023 and is predicted to reach USD 3.19 billion by the year 2031 at a 6.05% CAGR during the forecast period for 2024-2031.
Rheumatoid arthritis (RA) is diagnosed with the help of a combination of blood tests, imaging, and physical examination. A thorough physical examination of the joints for swelling and tenderness is also crucial. These tests together help confirm the diagnosis and determine the severity of RA.
By facilitating a fast diagnosis and the start of the right course of therapy, these tests help patients get better results. The accuracy and specificity of RA diagnostics are being improved by developments in diagnostic technology, including biomarker detection and DNA testing techniques, producing more dependable outcomes. The advantages of early recognition and illness surveillance are becoming more widely known to individuals and physicians, which is driving market expansion. The demand for RA diagnostic tests is growing as a result of proactive measures taken by government departments and medical institutions to expand the availability of testing services as well as enhance the quality of medical facilities.
However, the intricacy and diversity of illness appearance are the main obstacles facing manufacturers for RA diagnostic testing. A diverse range of medical signs and illness pathways describe rheumatoid arthritis, an inflammatory illness. Because of this heterogeneity, it can be difficult for doctors to diagnose RA correctly, particularly in the beginning phases when indications can mimic those of other autoimmune or rheumatic diseases. The method of diagnosis is made more difficult by the absence of particular diagnostics that differentiate RA from other types of rheumatism.
Furthermore, Regional regulatory systems are complicated and ever-changing, necessitating thorough documentation and strict adherence to standards. Delays in product launches and market entrance are common results of the time and money needed to meet these standards. Rising negative reimbursement circumstances and ongoing modifications to government regulations are among the primary challenges limiting industry expansion.
The rheumatoid arthritis diagnostic tests market is segmented based on test type and end user. Based on test type category, the market is segmented into serology tests and monitoring RA treatment efficiency tests. This test type segment is further divided into different sub segments like Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treatment Efficiency Tests (Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), Creatinine Test). By end user, the market is segmented into diagnostic laboratories, private laboratories, public laboratories, and ambulatory surgical centers.
The diagnostic laboratories' rheumatoid arthritis diagnostic tests market is anticipated to lead with a significant global market share. Owing to their sophisticated facilities and proficiency in carrying out a broad array of diagnostic examinations crucial for the identification and treatment of RA. Modern equipment, robotic procedures, and specialist staff skilled in carrying out the biological diagnostics, radiographic analyses, and serology tests required for Rheumatoid diagnostics are often found in these laboratories.
Serology tests are currently the dominant method because they play a fundamental role in diagnosing and monitoring rheumatoid arthritis (RA). These tests primarily identify antibodies, such as rheumatoid factor (RF) and anti-CCP (anti-cyclic citrullinated peptide) antibodies, that are important biomarkers linked to rheumatoid arthritis (RA).
The North American rheumatoid arthritis diagnostic tests market is expected to register the prominent market share in revenue in the near future. It can be attributed to increasing supportive government policies and a robust diagnostic system. In addition, Asia Pacific is likely to grow rapidly in the global rheumatoid arthritis diagnostic tests market because of the improvement of healthcare facilities and the increasing presence of many target groups in this region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.03 Bn |
|
Revenue Forecast In 2031 |
USD 3.19 Bn |
|
Growth Rate CAGR |
CAGR of 6.05% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type and End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Abbott Laboratories Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Exagen Inc., Augurex Life Sciences Corp., Danaher Corporation, Bio-Rad Laboratories, Inc., Tulip Diagnostics (P) Ltd, Boditech Med Inc., and Other Market Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Rheumatoid Arthritis Diagnostic Test Market Snapshot
Chapter 4. Global Rheumatoid Arthritis Diagnostic Test Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Test Type Estimates & Trend Analysis
5.1. By Test Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Test Type:
5.2.1. Serology Test
5.2.1.1. Erythrocyte Sedimentation Rate (ESR)
5.2.1.2. Rheumatoid Factor (RF)
5.2.1.3. Anti-cyclic Citrullinated Peptide (anti-CCP)
5.2.1.4. Antinuclear Antibody (ANA)
5.2.1.5. Uric Acid
5.2.1.6. Other Tests
5.2.2. Monitoring RA Treatment Efficiency Tests
5.2.2.1. Salicylate Level Count
5.2.2.2. Muscle Enzyme Tests (CPK, Aldolase)
5.2.2.3. Creatinine Test
Chapter 6. Market Segmentation 2: By End Users Estimates & Trend Analysis
6.1. By End Users & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End Users:
6.2.1. Diagnostic Laboratories
6.2.2. Private Laboratories
6.2.3. Public Laboratories
6.2.4. Ambulatory Surgical Centers
Chapter 7. Rheumatoid Arthritis Diagnostic Test Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.1.2. North America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.1.3. North America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.2. Europe
7.2.1. Europe Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.2.2. Europe Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.2.3. Europe Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.3.2. Asia Pacific Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.3.3. Asia Pacific Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.4. Latin America
7.4.1. Asia Pacific Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.4.2. Latin America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.4.3. Latin America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.5.2. Middle East & Africa Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.5.3. Middle East & Africa Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Abbott Laboratories Inc.
8.2.2. Siemens Healthineers AG
8.2.3. Thermo Fisher Scientific Inc.
8.2.4. Exagen Inc.
8.2.5. Augurex Life Sciences Corp.
8.2.6. Danaher Corporation
8.2.7. Bio-Rad Laboratories, Inc.
8.2.8. Tulip Diagnostics (P) Ltd
8.2.9. Boditech Med Inc.
8.2.10. Labcorp,
8.2.11. Antibodies Inc.,
8.2.12. Beckman Coulter, Inc.,
8.2.13. Euro Diagnostica AB,
8.2.14. F. Hoffmann-La Roche Ltd.,
8.2.15. Qiagen NV,
8.2.16. Specialty Networks, LLC
8.2.17. Genway Biotech, Inc.,
8.2.18. Microdrop LLC (imaware)
8.2.19. Svar Life Science AB,
8.2.20. Others Market Players
Rheumatoid Arthritis Diagnostic Tests Market By Test Type-
Rheumatoid Arthritis Diagnostic Tests Market By End User-
Rheumatoid Arthritis Diagnostic Tests Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
